{
Lupin Limited

Companies

}
001122334455554433221100
001122334455554433221100

global uveitis treatment market poised for significant growth by 2032

The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
openPR.com
Pfizer Inc. Bayer AG Novartis AG Regeneron Pharmaceuticals, Inc. Merck & Co., Inc. CIPLA LTD Lupin Limited Hoffmann-La Roche AG Bausch Health Companies Inc. BIOGEN ABBVIE Alimera Sciences Inc. SAU ISR FRA RUS DEU TWN ARG ARE AUT TUR SGP NZL CHL USA BRA CAN ITA JPN IDN GBR ESP IND MYS COL AUS THA EGY VNM KOR PHL CHN ZAF MEX Nidhi Bhavsar Show more
Healthcare, Market Report
20:41 19.12.2024

Global Generic Pharmaceuticals Market Sees Growth in Simple Generics and Biosimilars

India's "Pharmaceuticals Mission" aims to boost generic production, with simple generics leading the market due to cost-effectiveness and ease of manufacturing. Cardiovascular diseases drive demand, while small molecules dominate product types. Retail pharmacies remain the preferred distribution channel, and key players like Cipla and Teva are expanding their offerings.
GlobeNewswire News Room
United States Dollar Euro Fresenius Kabi AG Sanofi Aspen Pharmacare Holdings Ltd Sun Pharmaceuticals, Ltd. Aurobindo Pharma Limited Glenmark Pharmaceuticals Limited Pfizer Inc. Lupin Limited Dr. Reddy's Laboratories Limited Zydus Lifesciences Limited Teva Pharmaceuticals, Inc. Viatris Inc. Novartis AG Hikma Cipla Limited IND USA Show more
Healthcare, Market Report
16:30 04.12.2024

Lupin's growth prospects lead to target price increase by KR Choksey

KR Choksey has maintained an "ACCUMULATE" rating for Lupin, setting a target price of INR 2,472 per share. The company's revenue aligned with estimates, while EBITDA and adjusted PAT exceeded expectations due to lower costs. Anticipated growth from an expanding respiratory portfolio and upcoming product launches is expected to drive revenue growth of 13.4% CAGR and adjusted PAT growth of 38.3% CAGR from FY24 to FY26.
Moneycontrol
Indian Rupee Lupin Limited IND
Healthcare, Market Report
06:21 13.11.2024

Milan Vaishnav bullish on Lupin and ITC for November series

Milan Vaishnav, founder of Gemstone Equity Research & Advisory Services, is bullish on Lupin and ITC for the November series. He anticipates Lupin will rise to Rs 2,300-2,350, while ITC is expected to test Rs 505-510 in the coming weeks, reflecting a mixed approach from defensive and FMCG sectors.
Moneycontrol
Lupin Limited ITC Limited IND Milan Vaishnav
Finance & Economy, Market Report
01:57 03.11.2024

pharma sector faces growth slowdown while domestic market thrives

Pharma giants are experiencing a slowdown in earnings growth, primarily due to their reliance on the US generics market and a lack of major drug launches. Companies like Cipla, Dr Reddy's, and Aurobindo Pharma face challenges from rising competition and impending patent expirations, while midcap firms focused on the domestic market continue to thrive without the same pressures.
Moneycontrol
United States Dollar Aurobindo Pharma Limited SBI Life Insurance Company Ltd. Cipla Limited DR Reddy'S Laboratoire Ltd. TVS Motor Company Limited HUL Lupin Limited IND Lupin Spiriva Cipla Dr Reddy's Aurobindo Pharma Show more
Healthcare, Market Report
05:31 25.10.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Central Bank Actions Banking Regulations Retail and Consumer Goods Finance Mergers & Acquisitions Industry Mergers & Acquisitions Startups & Entrepreneurship Inflation and Monetary Impact Government Economic Policies CEO Changes Domestic Politics Market Analysis and Predictions Workplace Trends Government Policies Supply Chain Management GDP Growth & Recession Forecasts
Countries:
USA CHN GBR CHE DEU IND FRA JPN CAN VNM AUS MEX ITA ARE SGP THA ESP MYS TWN NLD
Companies:
Tesla, Inc. Apple Inc. Barclays PLC JPMorgan Chase & Co. Deutsche Bank Money Market PP Credit Suisse Strategic Income I The Goldman Sachs Group, Inc. Berkshire Hathaway Inc. UBS Group AG BNP Paribas SA Banco Santander, S.A. Lloyds Banking Group plc SpaceXCoin USD Bank of America Corporation Jenoptik AG Air France-KLM Amazon.com, Inc. NVIDIA Corporation Infineon Technologies AG Banco BPM S.p.A.
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Japanese Yen Indian Rupee Chinese Yuan Canadian Dollar Vietnamese Đồng South Korean Won Australian Dollar Thai Baht Indonesian Rupiah Singapore Dollar Mexican Peso Hong Kong Dollar Offshore Chinese Yuan New Zealand Dollar Cambodian Riel Myanmar Kyat
People:
Donald Trump Elon Musk JD Vance Sergio Ermotti Warren Buffett Mark Haefele Jennifer Piepszak Ursula von der Leyen Olivier Calvet Scott Bessent Karoline Leavitt George Saravelos Francois Xavier Bouvignies Joseph Spak Robin Leopold Susan P. Crawford Greg Rubini Dan Ives Narendra Modi Joe Biden

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.